What's Happening?
Researchers at Northwell Health’s Feinstein Institutes for Medical Research have received a $3.4 million grant from the National Institutes of Health (NIH). This funding will support the development of advanced artificial intelligence (AI) tools aimed
at detecting and preventing delirium in hospital settings, particularly among older patients. Delirium, a serious medical condition characterized by acute mental disturbance, is a significant risk factor for Alzheimer’s disease and related dementias (AD/ADRD). It often affects individuals over 65 during hospitalization and is frequently missed by clinicians in over 75% of cases, even with screening programs. The project, led by Dr. Liron Sinvani, Dr. Alex Makhnevich, and Dr. Theodoros P. Zanos, will create machine learning AI models to identify delirium in the emergency department (ED) and predict its onset during hospitalization. These models will utilize electronic health record data and continuous monitoring from wearable devices, with validation across diverse patient groups. The research will focus on three key areas: identifying delirium upon ED arrival, predicting its development in admitted patients, and integrating these AI tools into existing hospital workflows.
Why It's Important?
This initiative is crucial for improving patient safety and long-term health outcomes for older adults in U.S. hospitals. Delirium can lead to severe consequences, including falls, extended hospital stays, persistent memory problems, and an increased risk of developing Alzheimer’s disease. By enabling earlier and more accurate detection, the AI tools could significantly reduce these adverse effects. The current high rate of missed diagnoses for delirium highlights a critical gap in healthcare, which this grant aims to address. Proactive identification and prevention of delirium could alleviate the burden on medical staff, optimize hospital resources, and ultimately enhance the quality of care for a vulnerable patient population. Furthermore, by tackling a major risk factor for Alzheimer’s disease, this research contributes to broader efforts in brain health and cognitive decline prevention, which has substantial societal and economic implications given the rising prevalence of dementia.
What's Next?
The research team will proceed with developing and validating the machine learning AI models using extensive patient data, including the largest in-hospital wearable dataset in the U.S. The next steps involve refining the AI algorithms to accurately identify delirium in the ED and predict its occurrence during hospitalization. A critical phase will be the integration of these AI tools into real-world hospital workflows, requiring collaboration with doctors, nurses, and hospital administrators to ensure practical applicability and adoption. The project also aims to build and validate these tools using diverse patient groups, ensuring broad utility. Successful implementation could lead to widespread adoption of AI-powered delirium detection systems across U.S. healthcare facilities, potentially transforming geriatric care and preventative strategies for cognitive decline. Future efforts will likely involve further studies to assess the long-term impact of early delirium intervention on patient outcomes and healthcare costs.
Beyond the Headlines
This project signifies a broader shift towards leveraging artificial intelligence and machine learning in clinical settings to address complex medical challenges that human observation alone often misses. The use of wearable devices for continuous monitoring, combined with electronic health record data, represents a frontier in predictive healthcare, moving from reactive treatment to proactive prevention. Ethically, the development and deployment of such AI tools will necessitate careful consideration of data privacy, algorithmic bias, and the role of AI in clinical decision-making. Ensuring that these tools are equitable and effective across diverse patient populations will be paramount. Long-term, the success of this initiative could pave the way for similar AI applications in detecting other subtle, yet critical, medical conditions, fundamentally altering how hospitals manage patient care and potentially leading to a more personalized and predictive approach to medicine. This also highlights the growing importance of interdisciplinary collaboration between medical professionals and AI specialists.













